Malaria-infected mice are cured by a single low dose of a new silylamide trioxane plus mefloquine

Lauren E. Woodard, Bryan T. Mott, Vandana Singhal, Nirbhay Kumar, Theresa A. Shapiro, Gary H. Posner

Research output: Contribution to journalArticlepeer-review

Abstract

Three thermally and hydrolytically stable silylamide trioxanes have been prepared from the natural trioxane artemisinin in only five simple chemical steps and in at least 56% overall yield. Two of these new chemical entities completely cured malaria-infected mice at a single oral dose of only 8 mg/kg combined with 24 mg/kg of mefloquine hydrochloride. The high efficacy of this ACT chemotherapy is considerably better than the efficacy using the popular trioxane drug artemether plus mefloquine hydrochloride.

Original languageEnglish (US)
Pages (from-to)228-235
Number of pages8
JournalPharmaceuticals
Volume2
Issue number3
DOIs
StatePublished - Dec 2009

Keywords

  • Antimalarial monomers and dimmers
  • Silylamide trioxanes
  • Single dose oral cure

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Malaria-infected mice are cured by a single low dose of a new silylamide trioxane plus mefloquine'. Together they form a unique fingerprint.

Cite this